Sanofi is buying Vicebio, a biotech, that is developing vaccines for two viruses using the molecular clamp technology invented at the University of Queensland.

More proteins may be druggable with molecular glue degraders than initially thought, according to a new paper in Science from the biotech firm Monte Rosa Therapeutics. Molecular glues are small ...

After just a few months of work, a complete newcomer to the world of sphere packing has solved one of its biggest open problems.

An interaction between two proteins points to a molecular basis for memory. But how do memories last when the molecules that form them turn over within days, weeks, or months?

The Taurus Molecular Cloud is one of the closest and most well-known stellar nurseries, making it an easy place to study how stars are born and evolve. But it's not the only thing in this picture ...

Meet Bille, the name given to the world's first monostable tetrahedron—a four-faced object that will always land on the same side, no matter its starting position. This feat of geometry and ...

Mathematics Why physicists think geometry is the path to a theory of everything From four-dimensional hexagons to the mind-bending amplituhedron, geometrical shapes are wilder than we learn at ...

Abstracts presented during the plenary session of the 2025 European Hematology Association (EHA) Congress spanned from novel drug regimens for myeloma and lymphoma to investigation of leukemias on ...

Geometry Dash Odyssey showcases the combined talents of six brilliant creators, blending their unique styles into a cohesive masterpiece. Each segment of Geometry Dash Odyssey reflects the distinctive ...

The MIT model predicts molecular binding affinity at newfound speed and accuracy, offering a powerful tool for commercial drug discovery.

What’s outside this “flat” bubble of our universe is anyone’s guess. This shape supports the idea of a cosmos that expands forever.

Haemanthus, a blood testing startup from Billy Evans, partner of Elizabeth Holmes, has taken to X to say it's not 'Theranos 2.0.' ...